CHISLAINE MAXWELL -OAP IHD ACCT. For the Period 10/1/13 to 10/31/13 Prize Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Original Cost Accrued Div. Yield EAFE Equity MIN GROUP LTD SPONS ADR 62474M-10-8 MTNO Y 19.86 2,625.000 52,132.50 49,970.21 2,162.29 1,929.37 3.70% MUENCHENER RUECKVERSICHERUNGS - GESELLSCHAFT ADR 626188-10-6 MURG Y 20.95 2,610.000 54,679.50 48,665.02 8,014.48 1,618.20 2.96% NESTLE S A SPONS ADR REPSTG REG SH 641069-4043 NSRG Y 72.41 1,055.000 76,392.55 73,413.83 2.978.72 1,915.86 2.51 % NIPPON TEL & TEL COFtP ADR 654624-10-5 NTT 26.10 2210.000 57,881 .00 58,374.87 (693.87) 1,818.83 839.88 3.15% NOVARTM A 0 ADR 66987V-10-9 NVS 77.55 975.000 75,611.25 68,101.01 7,510.24 2,005.57 2_65% PROCEEDS FROM PENDING SALES 1.00 2,126.340 2.126.34 2126.34 RECKITT BENCKISER GROUP PLC SPONSORED ADR 756255-20-4 RBGL Y 15.56 3,540.000 55,082.40 48.749.99 8,332.41 1,454.94 2.64% ROCHE HOLDINGS LTD SPONS ADR 771195-10-4 RHHB Y 69.34 700.000 48,538.00 39,379.81 9,158.19 1,136.80 2.34% ROYAL DUTCH SHELL PLC ADR 780259-10-7 RDS B 69.52 400.000 27,808.00 27,957.37 (149.37) 1,440.00 5.18% SANOFI 80105N-10-5 SNY 53.48 1,195.000 83,908.60 60,068.51 3,840.09 1,499.72 2.35% J. P. Morgan Account Page 7 of 13 Consolidated Statement Page 45 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046304 SDNY_GM_00315502 EFTA01519036